OpenAlex
PricingAboutJobs
Log inGet started
Author

Zexian Wang

Institution: Xuzhou Medical College
Observed institution: Xuzhou Medical College
ORCID: 0009-0002-5890-4275
Observed ORCID: 0009-0002-5890-4275
OpenAlex ID: A5071100902
Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis
2026 · Zexian Wang, Yaru Guo, et al. · Clinical Medicine Insights Oncology
Chemotherapy plus Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor versus EGFR-TKI alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
2024 · Xiaohan Qin, Yaru Guo, et al.
PDF
Bevacizumab plus Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor versus EGFR-TKI alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
2023 · Zexian Wang, Yaru Guo, et al.
PDF
Works count: 3
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security